253 related articles for article (PubMed ID: 20083656)
1. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity.
Lombardi V; Stock P; Singh AK; Kerzerho J; Yang W; Sullivan BA; Li X; Shiratsuchi T; Hnatiuk NE; Howell AR; Yu KO; Porcelli SA; Tsuji M; Kronenberg M; Wilson SB; Akbari O
J Immunol; 2010 Feb; 184(4):2107-15. PubMed ID: 20083656
[TBL] [Abstract][Full Text] [Related]
2. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
[TBL] [Abstract][Full Text] [Related]
3. Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production.
Matsuda H; Takeda K; Koya T; Okamoto M; Shiraishi Y; Miyahara N; Dakhama A; Matsuda JL; Gapin L; Gelfand EW
J Immunol; 2010 Jul; 185(1):253-62. PubMed ID: 20525882
[TBL] [Abstract][Full Text] [Related]
4. Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta 2-microglobulin-deficient mice.
Koh YI; Kim HY; Meyer EH; Pichavant M; Akbari O; Yasumi T; Savage PB; DeKruyff RH; Umetsu DT
J Immunol; 2008 Oct; 181(7):4560-4569. PubMed ID: 18802058
[TBL] [Abstract][Full Text] [Related]
5. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.
Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361
[TBL] [Abstract][Full Text] [Related]
6. Invariant NKT cells act as an adjuvant to enhance Th2 inflammatory response in an OVA-induced mouse model of asthma.
Nie H; Yang Q; Zhang G; Wang A; He Q; Liu M; Li P; Yang J; Huang Y; Ding X; Yu H; Hu S
PLoS One; 2015; 10(4):e0119901. PubMed ID: 25830340
[TBL] [Abstract][Full Text] [Related]
7. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.
Hachem P; Lisbonne M; Michel ML; Diem S; Roongapinun S; Lefort J; Marchal G; Herbelin A; Askenase PW; Dy M; Leite-de-Moraes MC
Eur J Immunol; 2005 Oct; 35(10):2793-802. PubMed ID: 16180255
[TBL] [Abstract][Full Text] [Related]
8. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.
Lisbonne M; Diem S; de Castro Keller A; Lefort J; Araujo LM; Hachem P; Fourneau JM; Sidobre S; Kronenberg M; Taniguchi M; Van Endert P; Dy M; Askenase P; Russo M; Vargaftig BB; Herbelin A; Leite-de-Moraes MC
J Immunol; 2003 Aug; 171(4):1637-41. PubMed ID: 12902459
[TBL] [Abstract][Full Text] [Related]
10. Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model.
Renukaradhya GJ; Manickam C; Khatri M; Rauf A; Li X; Tsuji M; Rajashekara G; Dwivedi V
J Clin Immunol; 2011 Apr; 31(2):228-39. PubMed ID: 21042929
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms.
Araujo LM; Chauvineau A; Zhu R; Diem S; Bourgeois EA; Levescot A; Huerre M; Gombert JM; Bayry J; Daëron M; Bruhns P; Kaveri SV; Herbelin A
J Immunol; 2011 Mar; 186(6):3289-93. PubMed ID: 21317388
[TBL] [Abstract][Full Text] [Related]
12. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
13. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model.
Kim JO; Kim DH; Chang WS; Hong C; Park SH; Kim S; Kang CY
J Allergy Clin Immunol; 2004 Dec; 114(6):1332-8. PubMed ID: 15577831
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CD40L inhibits immunogenic maturation of lung dendritic cells: Implications for the role of lung iNKT cells in mouse models of asthma.
Deng N; Chen Q; Guo X; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Zhao Y; Chen X; Nie H
Mol Immunol; 2020 May; 121():167-185. PubMed ID: 32229377
[TBL] [Abstract][Full Text] [Related]
15. Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ.
Sakurai T; Inamine A; Iinuma T; Funakoshi U; Yonekura S; Sakurai D; Hanazawa T; Nakayama T; Ishii Y; Okamoto Y
Clin Exp Immunol; 2014 Oct; 178(1):65-74. PubMed ID: 24943738
[TBL] [Abstract][Full Text] [Related]
16. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
Yang JQ; Wen X; Kim PJ; Singh RR
J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
[TBL] [Abstract][Full Text] [Related]
17. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
18. Natural killer T cells are dispensable in the development of allergen-induced airway hyperresponsiveness, inflammation and remodelling in a mouse model of chronic asthma.
Koh YI; Shim JU; Lee JH; Chung IJ; Min JJ; Rhee JH; Lee HC; Chung DH; Wi JO
Clin Exp Immunol; 2010 Jul; 161(1):159-70. PubMed ID: 20456411
[TBL] [Abstract][Full Text] [Related]
19. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.
Kerzerho J; Yu ED; Barra CM; Alari-Pahissa E; Girardi E; Harrak Y; Lauzurica P; Llebaria A; Zajonc DM; Akbari O; Castaño AR
J Immunol; 2012 Mar; 188(5):2254-65. PubMed ID: 22301545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
